Earlier in the week, Aastrom filed an S3 registering 4.526 million shares of Class A warrants that relate back to the companies January 2010 financing. These warrants are exercisable by the holders at $2.52...(
read more)
Courtesy of Benzinga. Aastrom Biosciences (NASDAQ: ASTM) recently announced that results from its RESTORE Phase 2 clinical trial were positive, and [...]
Molecular Insight Pharmaceuticals, Inc. (NASDAQ:MIPI) is having a real bad day here on Friday. The stock is the top decliner of the NASDAQ. Today the news...(
read more)